Liquid Biopsy Market Size, Share & Industry Analysis, By Product (Kits & Reagents, and Instruments), By Application (Oncology, Non-invasive Prenatal Testing (NIPT), and Others), By End User (Hospitals, Clinical Laboratories, and Others), and Regional Forecast, 2025-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate 

CAGR of 25.9% from 2025-2032

Unit

Value (USD Billion)

Segmentation

By Product

• Kits & Reagents
• Instruments

By Application

• Non-invasive Prenatal Testing (NIPT)
• Oncology
• Others

By End User

• Hospitals
• Clinical Laboratories
• Others

By Region

• North America (By Product, By Application, By End User, and By Country)
  • U.S. (By Application)
  • Canada (By Application)
• Europe (By Product, By Application, By End User, and By Country/ Sub-region)
  • Germany (By Application)
  • U.K. (By Application)
  • France (By Application)
  • Italy (By Application)
  • Spain (By Application)
  • Rest of Europe ((By Application)
• Asia Pacific (By Product, By Application, By End User, and By Country/ Sub-region)
  • Japan (By Application)
  • China (By Application)
  • India (By Application)
  • Australia (By Application)
  • Southeast Asia (By Application)
  • Rest of Asia Pacific (By Application)
• Latin America (By Product, By Application, By End User, and By Country/ Sub-region)
  • Brazil (By Application)
  • Mexico (By Application)
  • Rest of Latin America (By Application)
• Middle East & Africa (By Product, By Application, By End User, and By Country/ Sub-region)
  • GCC (By Application)
  • South Africa (By Application)
  • Rest of Middle East & Africa (By Application)